Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 628-856-6 | CAS number: 1218787-29-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 March 2010 - 23 April 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD No. 406 (1992) "Skin Sensitization" EC No 440/2008; B6: "Skin Sensitization: Guinea-Pig Maximization Test (GPMT)" EPA OPPTS 870.2600 (2003) “Skin Sensitization” JMAFF Guidelines (2000) including the most recent partial revisions.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- LLNA was not required under REACH at the time of testing. A valid GPMT test exists on the substance, therefore it is unncessary to produce a new test using animals.
Test material
- Reference substance name:
- C12-18 evennumbered alkyl nitrile
- EC Number:
- 628-856-6
- Cas Number:
- 1218787-29-1
- Molecular formula:
- No molecular formula
- IUPAC Name:
- C12-18 evennumbered alkyl nitrile
- Details on test material:
- - Name of test material (as cited in study report): Coconitrile
- Substance type: Clear amber liquid (determined at NOTOX)
- Physical state: liquid
- Analytical purity: 101.0 w/w%
- Isomers composition: 6% C8 / 8% C10 / 50% C12 / 18% C14 / 8% C16 / 10% C18
- Purity test date: 08-10-2008
- Lot/batch No.: S001069
- Expiration date of the lot/batch: 08 November 2017
- Stability under test conditions: Stability under storage conditions = Stable / Stability in vehicle (Corn oil) = Not indicated
- Storage condition of test material: At room temperature in the dark under nitrogen
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Kisslegg, Germany
- Age at study initiation: approx. 6-7 weeks old
- Weight at study initiation:
- Housing: Group housing of maximally 5 animals per labeled cage (74 cm x 54 cm x 25 cm height) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France).
- Diet (e.g. ad libitum): Complete breeding diet for guinea pigs (SSNIFF® MS-Z, V2273; SSNIFF® Spezialdiäten GmbH, Soest, Germany). Hay (TecniLab-BMI BV, Someren, The Netherlands) was provided at least twice a week.
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: At least 5 days before the start of treatment under laboratory conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17.5 – 20.7ºC
- Humidity (%): 23 - 95%
- Air changes (per hr): approximately 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light and 12 hours darkness per day.
IN-LIFE DATES: From: 09 March 2010 To: 23 April 2010
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- corn oil
- Concentration / amount:
- intradermal inductie: 50%
epidermal inductie: 100%
Challange: 0 and 100%
Re-challange: 50 and 100%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- intradermal inductie: 50%
epidermal inductie: 100%
Challange: 0 and 100%
Re-challange: 50 and 100%
- No. of animals per dose:
- Experimental group: 10 females.
Control group: 5 females. - Details on study design:
- RANGE FINDING TESTS:
Series of test substance concentrations were tested (0.5/1/2/5/10/20/50/100%).
The test system and procedures were identical to those used during the main study, unless otherwise specified.
The four animals selected were between 4 and 9 weeks old. No body weights were determined.
MAIN STUDY
A. INDUCTION EXPOSURE
-Day 1
The scapular region was clipped and three pairs of intradermal injections (0.1 mL/site) were made in this area as follows:
A) A 1:1 w/w mixture of Freunds' Complete Adjuvant (Difco, Detroit, U.S.A.) with water for injection (Fresenius AG, Bad Homburg, Germany).
B) The test substance at a 50% concentration.
C) A 1:1 w/w mixture of the undiluted test substance and Freunds' Complete Adjuvant.
Note: One of each pair was on each side of the midline and from cranial A) to caudal C).
Day 3
The dermal reactions caused by the intradermal injections were assessed for irritation.
Day 7
The scapular area between the injection sites was clipped and subsequently rubbed with 10% sodium-dodecyl-sulfate (SDS, Boom, Meppel, The Netherlands) in vaseline using a spatula. This concentration of SDS provokes a mild inflammatory reaction.
Day 8
The 10% SDS treated area between the injection sites was treated with 0.5 mL of a 100% test substance concentration using a Metalline patch (2x3 cm) mounted on Medical tape, which was held in place with Micropore tape and subsequently Coban elastic bandage.
The dressing was removed after 48 hours exposure, the skin cleaned of residual test substance using water and the dermal reactions caused by the epidermal exposure were assessed for irritation.
B. CHALLENGE EXPOSURE
-Day 21
One flank of all animals was clipped and treated by epidermal application of a 100% test substance concentration and the vehicle (0.1 mL each), using Patch Test Plasters (Curatest®, Lohmann, Almere, The Netherlands). The patches were held in place with Micropore tape and subsequently Coban elastic bandage.
The dressing was removed after 24 hours exposure and the skin cleaned of residual test substance and vehicle using water. The treated sites were assessed for challenge reactions 24 and 48 hours after removal of the dressing.
Day 28 A re-challenge was conducted approximately one week after the first challenge, to clarify the results in the first challenge. The contralateral flank of all animals was similarly treated. All animals were treated epidermally with 0.05 mL of each of the following test substance concentrations, 100% and 50% on a clipped flank, using Square chambers, attached to Micropore tape and secured with Coban elastic bandage.
The dressing was removed after 24 hours exposure and the skin cleaned of residual test substance and vehicle using water. The treated sites were assessed for challenge reactions 24 and 48 hours after removal of the dressing.
After termination, animals were sacrificed by intra peritoneal injection of pentobarbital (Euthesate®; Sanofi Sante B.V., Maassluis, The Netherlands).
In life examinations:
Mortality/Viability: Twice daily
Toxicity: At least once daily.
Body weights: Prior to start and at termination of the study.
Irritation:
Skin reactions were graded according to the following numerical scoring systems. Furthermore, a description of all other (local) effects was recorded.
To facilitate scoring, the epidermally treated skin-areas were clipped at least 3 hours before the 48-hour reading of these areas in the preliminary irritation study and challenge phase. - Positive control substance(s):
- yes
- Remarks:
- Alpha-Hexylcinnamicaldehyde
Results and discussion
- Positive control results:
- Reliability test:
Was performed not more than 6 months previously. Similar procedures were used in the reliability test and in this study.
The skin reactions observed in seven experimental animals in response to the 20% test substance concentration in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals. These results lead to a sensitisation rate of 70 per cent to the 20% concentration.
From these results, it was concluded that the female guinea pig of the Dunkin Hartley strain is an appropriate animal model for the performance of studies designed to evaluate the sensitizing potential of a substance in a Maximization type of test.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 3.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: control
- Dose level:
- 0
- No. with + reactions:
- 1
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: control. Dose level: 0. No with. + reactions: 1.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 2.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 1.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 1.0. Total no. in groups: 10.0.
Any other information on results incl. tables
Grading Irritation Reactions*:
Erythema and eschar formation:
No erythema..........................................................................................................................0
Slight erythema (barely perceptible).................................................................................1
Well-defined erythema.........................................................................................................2
Moderate erythema...............................................................................................................3
Severe erythema (beet redness) to slight eschar formation (injuries in depth).......4
Oedema formation:
No oedema...................................................................................................................... ........0
Slight oedema (barely perceptible).............................................................................. .......1
Well-defined oedema (edges of area well-defined by definite raising)........................2
Moderate oedema (raised approximately 1 millimeter)...................................................3
Severe oedema (raised more than 1 millimeter and extending beyond the area of exposure)..................................................................................................................................4
(*. Intradermal reactions were assessed for erythema only or, if necrosis is present, the diameter of necrosis.)
Grading Challenge Reactions:
No visible change..................................................................................................................0
Discrete or patchy erythema................................................................................................1
Moderate andfluent erythema..............................................................................................2
Moderate erythema and swelling.......................................................................................3
Intense erythema and swelling...........................................................................................4
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- The skin reactions that were confirmed in the second challenge in one (of the ten) experimental animals in response to a 100% test substance concentration consisted of a grade 1 reaction (discrete or patchy erythema), and was considered indicative of sensitization, based on the absence of any response in the control animals. These results indicate a sensitization rate of 10 per cent.
It was discussed with the sponsor that “According to the guidelines and if the results indicate a sensitization rate of >0% and <30% an extension of the study with another set of 10 experimental and 5 control animals is strongly recommended. A definitive classification will then be based on the results of the total of 20 experimental and 10 control animals“. It was decided not to do this and terminated the study. - Executive summary:
PRELIMINARY IRRITATION STUDY
The results of the intradermal injections and epidermal exposures for the selection of suitable test substancecentrations for the main study are described in Table 1.
Based on the results, the test substancecentrations selected for the main study were a 50%centration for the intradermal induction and a 100%centration for the epidermal induction exposure.
No evident signs of irritation were observed to the highest test substancecentration epidermally tested. Therefore, the test site of all animals was treated with 10%approximately 24 hours before the epidermal induction in the main study, to provoke a mild inflammatory reaction.
A 100% test substancecentration was selected for the challenge phase.
MAINSTUDY
The skin effects caused by the intradermal injections and epidermal exposure during the induction phase are reported. All animals showed considerable necrosis following intradermal injections of test substance during the induction phase.
Subsequent epidermal induction exposure on day 10 resulted to reaction of grade 1 or 2 in 60% of the animals, although such treatment has shown not to result to dermal effects in the preliminary irritation study. The reactions noted in the experimental and control animals after the epidermal induction exposure were considered to be enhanced by the treatment.
First Challenge
Skin reactions of grade 1 were observed in one control animal and in three experimental animals in response to the 100% test substancecentration.
Because of the FCA treatment, the threshold for irritation could be possibly lowered for subsequent dermal exposure, explaining de response following epidermal induction, and the (slight) response in treated animals on this first challenge. In order to obtain a clearer response, a second challenge was performed.
Second challenge
Since it could not be decided whether the substance is a sensitizer or not, a sed challenge was performed one week later. The animals were then treated with a 100% and a 50% test substancecentration. Skin reactions of grade 1 were observed in one experimental animal and scaliness in another in response to the 100% test substancecentration. No skin reactions were evident in the control animals.
No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study.
Body weights and body weight gain of experimental animals remained in the same range astrols over the study period.
The skin reactions that were confirmed in the second challenge in one (of the ten) experimental animals in response to a 100% test substance concentration were considered indicative of sensitization, based on the absence of any response in the control animals. These results
indicate a sensitization rate of 10 per cent.
Formally, OECD guideline indicates that in cases of doubt (defined as all results showing response between 0 and 30%) additional 10 animals and 5 controls should be used. However, it was considered that additional animals would not lead to more positive reactions reaching to an overall average of ≥ 30%, and in view of animal welfare considerations it was therefore deicded that there is no need for testing on additional animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.